R&D | April 14, 2026
Aragen launches ChemiSHE, India’s first women-led chemistry synthesis lab
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
CRDMO plans to add 800–1,000 women across scientific and leadership roles over three years
BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
A brand from Opella will be part of the official NASA astronaut formulary
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
Paves the way for next-gen ultra-precise gas sensing
The license is valid for five years, effective from April 9, 2026
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Subscribe To Our Newsletter & Stay Updated
